Coeliac Disease Trial, Recruiting NCT06710067 Sponsor: Luventix, Inc. Condition: Coeliac Disease
Back to Coeliac Disease

Coeliac Disease Trial, Recruiting

NCT06710067
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older when you sign up for the study.
  • You must be able and willing to provide a single urine sample and follow all study procedures.
  • You must be able to understand what the study involves, agree to take part, and be willing to sign a form allowing the study team to access relevant medical information.

Who may not be able to join:

  • You cannot join if you are currently pregnant.
  • You may not be able to join if you have a health condition that the study doctor or sponsor believes would make it unsafe or unsuitable for you to participate (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: John Spinosa, MD, PhD, Luventix, Inc.

Phone: 888-404-3143

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Luventix, Inc.
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
1 September 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Disease signal detection; Test performance measures

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov